SOMERVILLE, N.J., Aug. 23-- Johnson and Johnson issued the following news release: Spectrum Health realized …
Johnson & Johnson's history of paying dividends dates back well into the past. For 55 years, the company has given its shareholders annual dividend increases, and that has earned it a spot among the elite Dividend Aristocrats. Even within …
JNJ reported Q3 earnings last month ... those repurchased shares would have otherwise received. The stock also trades at about 15x earnings, net of excess cash on the balance sheet – an ostensibly fair price to pay. Perhaps this was also a …
At Johnson & Johnson, the world’s largest health care company ... J&J’s 2014 profit forecast was slightly lower than analysts’ expectations, which sent the stock down 2.6 percent on Wall Street, before climbing back up. It finished the …
Johnson & Johnson’s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense. The $21.3 billion deal will give Johnson & Johnson a leading position in the main orthopedic device markets. …
Under the ASR agreements Janssen Pharmaceutical will purchase shares of Johnson & Johnson common stock that the banks will have borrowed from stock lenders, and during the term of the ASR agreements the banks are expected to …
CHICAGO, Oct. 9, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIS, JNJ, LLY, MZOR, …
Specifically, a jury ordered JNJ to pay $110 million to a Virginia woman who developed ovarian cancer after using the blue chip's talc-based products. As such, VRX stock is trading down 1.3% at $9.71 -- on track to end a relatively upbeat …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …